Healthcare News – Read More A federal appeals court on Wednesday ruled against a lawsuit filed by representatives of the pharmaceutical industry challenging the federal Medicare drug price negotiation program, finding that drugmakers are not entitled to sell their products to Medicare at a price they would prefer. The U.S. Court of Appeals for the 5th Circuit affirmed a prior…
Federal court rejects PhRMA challenge to Medicare drug price negotiation
HootMD curates medical news from trusted publishers. Follow the links in this article to read the full story at the original source.
